Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 3SBIO INC Ord Shs TRSBF

Healthcare Biotechnology
3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company’s main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)ainhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:TRSBF)

3SBio Unveils 2017 Annual Results: Revenue Soars by 33.5%

Stockhouse Editorial March 26, 2018

China FDA Approves New Once-Weekly Bydureon(R) to Improve Glycemic Control in Patients with Type-2 Diabetes

Stockhouse Editorial January 4, 2018

3SBio Accelerates Expansion of its Global Biologics Platform by Acquiring the Canadian Biomanufacturing Business of Therapure

PR Newswire September 3, 2017

3SBio Inc. Appoints Dr. Zhenping Zhu as President of Research & Development and Chief Scientific Officer

Stockhouse Editorial January 9, 2017

3SBio Inc. Announces Completion of Merger

PR Newswire May 30, 2013

3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

PR Newswire May 24, 2013

3SBio Inc. Announces Extraordinary General Meeting of Shareholders

PR Newswire May 2, 2013

3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

PR Newswire May 1, 2013

3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders

PR Newswire April 25, 2013
View More News ››

Opinion & Analysis (OTCPK:TRSBF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:TRSBF)

A small update...

SSRX (NASDAQ), which recently traded up around $7.80, has sunk back down to $5.24. A quick summary: - no debt - working capital of $5.10...
theinvestor22 - February 20, 2009

It's getting silly again!!

The price, that is.After deducting cash from today's stock price, the p/e is about 1x.  That's a tad low for a great growth...
theinvestor22 - January 22, 2009

Interesting!

Academically speaking, if someone could acquire the whole company at these prices, they could use SSRX's cash on hand to close the...
theinvestor22 - November 24, 2008

Ah, enlightenment

After listening to the Q3 08 preliminary earnings conference call, I can see I need to update my posting of yesterday, specifically:...
theinvestor22 - November 3, 2008

News - Write-off and Preliminary Q3

First, let's deal with the write-off.  If the $2.7M is all that is affected by the financial crisis in the United States, then...
theinvestor22 - November 1, 2008

Now down to a p/e of just 1.1x

The current stock price is approaching the level of cash on hand.  Not only is this a ridiculous situation for a company with such...
theinvestor22 - October 28, 2008
View more Bullboard ››

Nextleaf Solutions Ltd

Nextleaf Solutions Ltd

Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market ...
View More »